免疫球蛋白/希斯胺复合体对与慢性自发疹并发的恐慌障碍的影响:一个病例报告
Hyuk Soon Kim1, Geunwoong Noh2
1Department of Biomedical Sciences, College of Natural Science and Department of Health Sciences, The Graduate School of Dong-A University, Busan, South Korea.
Journal of medical case reports
|July 27, 2023
概括
本案例研究表明,免疫球蛋白/希斯胺复合疗法成功治疗了患有慢性自发性疹 (CSU) 和恐慌症的患者. 治疗还改善了焦虑和抑郁症状,这表明基因组胺与精神疾病之间存在联系.
科学领域:
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
- 过敏 过敏是一种过敏.
背景情况:
- 恐慌症和恐慌发作是常见的精神疾病.
- 建议过敏疾病和恐慌症之间存在联系.
- 希斯胺H1受体对抗剂和免疫球蛋白/希斯胺复合体正在研究治疗.
研究的目的:
- 报告患者同时患有慢性自发性疹 (CSU) 和恐慌障碍的成功治疗情况.
- 调查免疫球蛋白/希斯胺复合疗法对这些疾病的疗效.
主要方法:
- 一名52岁的女性患者,前23年患有CSU和恐慌症,每周接受免疫球蛋白/基因组复合物 (HistobulinTM) 的皮下注射.
- 在治疗前,治疗期间和治疗后进行过敏测试,疹严重程度评分和心理评估 (BDI-2,STAI,BHS).
- 诊断面试评估了恐慌障碍标准 (DSM-V).
主要成果:
- 患者在27次注射后实现了CSU的缓解,过敏性鼻炎完全消失,普通感冒的频率减少.
- 包括失眠在内的恐慌症症状与CSU缓解同时消失.
- 抑郁,焦虑和绝望的心理评估得分显著改善.
结论:
- 免疫球蛋白/希斯胺复合疗法对该患者的CSU和恐慌障碍都有效.
- 基因组胺可能在恐慌症中发挥作用,这表明基因组胺介导综合征和精神疾病之间存在潜在联系.
- 需要进一步研究恐慌障碍的免疫病原发生和免疫球蛋白/希斯胺复合物的作用机制.
相关概念视频
Allergic Reactions
Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...


